The Window To The Liver - A Comprehensive Overview Of The Clinical Application Of Menghini Liver Biopsy Needle

The Window to the Liver - A Comprehensive Overview of the Clinical Application of Menghini Liver Biopsy Needle
When abnormalities occur in the "silent organ" of the liver, pathological diagnosis is the indispensable "gold standard". And the Menghini liver biopsy needle is one of the most classic and commonly used keys for clinicians to obtain this "window of insight". Its application scope covers a wide range from diffuse lesions to focal tumors, providing crucial histological evidence for the precise diagnosis, staging, efficacy assessment, and formulation of individualized treatment plans of liver diseases.
Core diagnostic area: Assessment of diffuse liver diseases. This is where the Menghini needle is most traditionally and importantly applied. For chronic viral hepatitis (both hepatitis B and hepatitis C), biopsy not only confirms the degree of inflammation but also precisely quantifies the stage of liver fibrosis, which is crucial for determining whether and when to initiate antiviral treatment. In the assessment of non-alcoholic fatty liver disease (NAFLD) and its more severe stage - non-alcoholic steatohepatitis (NASH), the tissue samples obtained by the Menghini needle can distinguish simple steatosis from NASH with inflammation and ballooning degeneration, and can accurately grade the degree of fibrosis, which is crucial for prognosis judgment. When liver cirrhosis is suspected, although studies have indicated that cutting needles (such as Tru-Cut) may have a slight advantage in obtaining longer and more complete samples, the Menghini needle, with its rapid and low-trauma characteristics, can also obtain high-quality samples containing sufficient number of portal areas (suggesting at least 6-8) through appropriate techniques (such as using a 1.6mm diameter needle and two punctures), effectively diagnosing liver cirrhosis and reducing false negatives.
Differential diagnosis and tumor assessment. For liver space-occupying lesions identified by imaging, the Menghini needle can be precisely punctured under ultrasound or CT guidance to help differentiate between hepatocellular carcinoma (HCC), cholangiocarcinoma, metastatic tumors, and benign lesions (such as hemangioma, focal nodular hyperplasia, etc.). The obtained strip-like tissue samples can not only be used for routine HE staining but also meet the requirements of special staining such as immunohistochemistry (IHC), providing conclusive evidence for the origin and classification of the tumor.
Efficacy Monitoring and Frontier Exploration. During the treatment of chronic liver diseases, repeated liver biopsies are one of the most objective endpoint indicators for evaluating the efficacy of drugs (such as antiviral drugs, new NASH drugs). The minimally invasive nature of the Menghini needle makes it more suitable for this dynamic monitoring. Moreover, with the development of precision medicine, the value of biopsy samples has exceeded traditional morphology. High-quality Menghini needle samples can preserve DNA, RNA and proteins intact, thereby supporting molecular tests such as fluorescence in situ hybridization (FISH), gene sequencing, and proteomics, for finding drug targets, predicting treatment responses and evaluating prognosis, truly achieving a leap from "one-size-fits-all" to "tailored treatment" in individualized therapy.
Based on the customizable specifications provided by manufacturers such as Manners Technology (such as different needle diameters ranging from 16G to 20G and various lengths), the modern Menghini needles can flexibly meet the diverse clinical needs ranging from children to adults, and from mild fatty liver to advanced liver cirrhosis. It has evolved from a simple sampling tool into a core bridge connecting clinical phenotypes with microscopic pathology and even molecular biology.